Innovative Industrial Properties, Inc.

Innovative Industrial Properties, Inc. (IIPR) Market Cap

Innovative Industrial Properties, Inc. has a market capitalization of $1.71B.

Price: $58.81

-1.97 (-3.24%)

Market Cap: 1.71B

NYSE · time unavailable

CEO: Paul E. Smithers

Sector: Real Estate

Industry: REIT - Industrial

IPO Date: 2016-12-01

Website: https://www.innovativeindustrialproperties.com

Innovative Industrial Properties, Inc. (IIPR) - Company Information

Market Cap: 1.71B|Sector: Real Estate

Company Profile

Innovative Industrial Properties, Inc. is an independently managed, Maryland-based corporation primarily focused on acquiring, owning, and overseeing unique real estate assets. These properties are subsequently leased to experienced, state-licensed operators who utilize them for their regulated medical cannabis facilities. For tax purposes, the company adopted the structure of a Real Estate Investment Trust (REIT) starting from the end of 2017.

Analyst Sentiment

57%
Buy

From 6 Active Polls

1Y Forecast: $84.67

▲ +44.0% Potential Upside

Consensus Target Metrics

Low Bound

$44

Median

$60

High Bound

$150

Average

$85

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$84.67
▲ +43.97% Upside
Low Target
$44.00
-25% Risk
Median Target
$60.00
2% Mid
High Target
$150.00
155% Max
Consensus
Hold
4 / 11 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)1,7051,4041,3221,4961,5421,5291,8833,8033,044
Enterprise Value ($M)1,9821,6811,6681,7991,7321,6912,0353,9533,220
Price to Earnings Ratio (P/E)14.7412.0611.0713.2615.8712.8812.0724.3818.58
Price/Earnings-to-Growth Ratio (PEG)3.443.634.6542.383.23
Price to Sales Ratio (P/S)6.4820.3519.8323.1224.5221.3224.5349.7038.15
Price to Book Ratio (P/B)0.870.740.720.800.820.800.971.951.56
Price to Free Cash Flow Ratio (P/FCF)8.6526.4526.4932.8031.8328.2046.3558.6347.41
Enterprise Value to Sales (EV/Sales)24.3625.0227.8127.5423.5826.5151.6640.36
Enterprise Value to EBITDA (EV/EBITDA)9.1629.0729.2134.2935.3731.3333.1563.1750.49
Debt to Equity Ratio1.280.190.210.180.150.150.150.150.15

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 INNOVATIVE INDUSTRIAL PROPERTIES I (IIPR) — Investment Overview

🧩 Business Model Overview

IIPR is a specialized REIT that owns and operates industrial real estate tailored to regulated cannabis uses. The core “how it works” is straightforward: IIPR sources and structures facilities for licensed operators (often through sale-leaseback and build-to-suit transactions), then monetizes the properties via long-duration leases that transfer a substantial portion of operating costs to tenants.

This model creates operational stickiness because the assets are not generic warehouses; they are typically configured for compliance-oriented cultivation/processing requirements, with lease structures designed around the tenant’s need for continuity of location, permitting alignment, and operational readiness.

💰 Revenue Streams & Monetisation Model

Revenue is primarily rental income under lease agreements. The monetisation mix is structurally lease-driven rather than property-sale-driven: rent streams tend to be recurring, supported by lease terms that often include fixed contractual escalators and tenant responsibility for many ongoing property expenses.

Margin drivers are largely “REIT economics”:

  • Lease durability: Long lease terms can smooth rental cash flows relative to cyclical real estate segments.
  • Escalation mechanics: Contractual rent growth can partially offset inflationary pressures.
  • Expense pass-through: Triple-net style components (or close equivalents) reduce operating cost variability for IIPR.
  • Capital allocation discipline: Profitability depends on acquisition/build returns relative to the cost of capital and the quality of tenant covenants.

🧠 Competitive Advantages & Market Positioning

IIPR’s competitive positioning is best understood as a specialist landlord with regulatory and design experience in cannabis-adjacent industrial real estate. The moat is less about “owning land” and more about building a repeatable ability to place capital into compliant facilities and secure long-term tenant occupancy.

Moat thesis:

  • Switching costs (tenant operational continuity): Moving cannabis operations is not just a lease move; it can require new equipment layouts, licensing alignment, permitting, and operational ramp-up—making tenants value location continuity.
  • Specialized property configuration & execution: Purpose-fit facilities and landlord know-how lower execution risk for operators compared with negotiating generic industrial space conversions.
  • Regulatory/structural barriers: Competitors without cannabis-specific underwriting capability face higher due diligence friction and greater uncertainty around tenant compliance and lease durability.

Competitive benchmarking (industrial real estate alternatives):

  • Prologis (PLD): Large-scale industrial operator with broad exposure to logistics real estate; typically focuses on diversified, non-cannabis-specific tenant needs.
  • First Industrial Realty Trust (FR) / Duke Realty (DRE): Industrial REIT peers with conventional logistics and light industrial positioning rather than cannabis-specialist build and leasing workflows.
  • Private industrial landlords / local commercial owners: Often compete on availability of general space, but may lack the standardized, cannabis-execution discipline that supports tenant continuity and lease structure.

Compared with these rivals, IIPR’s market focus is narrower: cannabis-oriented industrial facilities and sale-leaseback/build-to-suit transactions for licensed operators. That specialization can raise barriers for generalized industrial landlords that must balance underwriting, compliance know-how, and tenant concentration risk.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, IIPR’s growth potential is tied to the maturation of regulated cannabis markets and the industry’s need for scaled, compliant real estate.

  • Market legalization and re-licensing breadth: As more jurisdictions permit regulated activity, operators require compliant capacity, not just raw land.
  • Facility professionalization: The industry trend toward more standardized cultivation/processing and tighter compliance creates demand for purpose-built or expertly adapted facilities.
  • Operator consolidation: As the market consolidates, larger operators often need stable facility footprints with operational continuity—supporting longer landlord-tenant relationships.
  • Capital markets access and deal repeatability: Specialized REIT structures can repeatedly finance acquisitions/builds that generalized landlords may not underwrite at scale.

⚠ Risk Factors to Monitor

  • Regulatory and policy risk: Changes to licensing rules, compliance requirements, or enforcement priorities can affect tenant viability and the realizable value of facilities.
  • Tenant concentration and credit risk: Cannabis operators can face volatility from pricing, demand fluctuations, and financing constraints; lease collectability and covenant strength matter.
  • Obsolescence and repositioning risk: If facility designs become less aligned with evolving regulatory/compliance needs, asset re-tenanting may be slower or require incremental capital.
  • Capital intensity and interest-rate sensitivity: New acquisitions/builds depend on financing conditions and disciplined underwriting; leverage and cost of capital can affect per-deal returns.
  • Reputation and compliance administration: Landlord risk increases if tenant compliance failures cascade into rent collection or lease enforcement complexity.

📊 Valuation & Market View

The market typically values IIPR-like REITs using a REIT lens, where value is driven by cash-flow durability and the quality of contracted rent rather than pure real estate “turn” economics. Common valuation frameworks include:

  • Cash flow multiples: Investors often anchor on AFFO-/FFO-like earnings power and the sustainability of rent growth and occupancy.
  • Balance sheet and cost of capital: Leverage, interest-rate environment, and access to financing influence distributable cash flow.
  • Property-level drivers: Lease duration, credit quality, tenant retention, and expense pass-through strength can move valuation more than broad industrial REIT comps.

Key valuation sensitivities for this business model are the perceived durability of lease cash flows and the expectation for stable reinvestment returns across new facilities.

🔍 Investment Takeaway

IIPR offers an evergreen, specialist REIT thesis: a narrow underwriting focus on cannabis-oriented industrial facilities can generate structural tenant stickiness through switching costs and operational continuity, reinforced by regulatory and execution barriers that general industrial landlords face. Long-duration lease economics, expense pass-through dynamics, and deal repeatability underpin the investment case, while the primary risks remain regulatory uncertainty, tenant credit cycles, and facility repositioning sensitivity as cannabis regulations and operating models evolve.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for IIPR.

gurufocus.com2026-07-31

Innovative Industrial Properties Inc (IIPR) Stock Down 3.2% -- Now Undervalued? GF Score: 78/100

On July 31, 2026, Innovative Industrial Properties Inc (IIPR) shares fell 3.2% to a current price of $58.81, reflecting a challenging market sentiment. Over the

defenseworld.net2026-07-30

Arrowstreet Capital Limited Partnership Raises Position in Innovative Industrial Properties, Inc. $IIPR

Arrowstreet Capital Limited Partnership increased its stake in Innovative Industrial Properties, Inc. (NYSE: IIPR) by 3,423.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 539,600 shares of the company's stock after purchasing an additional 524,284 shares during the quarter. Arrowstreet Capital Limited

zacks.com2026-07-28

Innovative Industrial Properties (IIPR) Stock Dips While Market Gains: Key Facts

In the latest trading session, Innovative Industrial Properties (IIPR) closed at $60.57, marking a -1.38% move from the previous day.

zacks.com2026-07-28

4 High Shareholder Yield Stocks to Buy Amid Rising Uncertainty

Amid rising market uncertainty, HSBC, MO, AMG and IIPR stand out for their strong shareholder yields, supported by dividends, share buybacks and debt reduction.

zacks.com2026-07-28

These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

zacks.com2026-07-21

Innovative Industrial Properties (IIPR) Stock Sinks As Market Gains: Here's Why

In the most recent trading session, Innovative Industrial Properties (IIPR) closed at $63.26, indicating a -1.69% shift from the previous trading day.

businesswire.com2026-07-20

Innovative Industrial Properties Announces Second Quarter 2026 Earnings Release Date and Conference Call

SAN DIEGO--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR) announced today it will report its second quarter 2026 results after the close of trading on the New York Stock Exchange on Monday, August 3, 2026. Management will host an investor conference call at 9:00 a.m. Pacific Time on Tuesday, August 4, 2026, to discuss the company's financial results and operations for the quarter. The call will be available through a live audio webcast at the Investor Relations secti.

seekingalpha.com2026-07-18

AI Bubble Risks Make Dividend Stocks Attractive Again

I identify dividend stocks and REITs that could protect investors from AI bubble risks, geopolitics, and inflation while generating attractive income. My "ALLKA Dividend Rating" model separates quality dividend opportunities from yield traps by analyzing dividend sustainability, growth prospects, and valuation. The article explores three dividend strategies, "High-Yield Defensive," "Balanced Income," and "Pure Growth," designed for goals ranging from high yield to dividend growth.

seekingalpha.com2026-07-11

The REIT Strategy I Would Use To Retire Today

Retirement income requires more than just high yield. REIT funds may not be the best solution. A balanced REIT portfolio can offer income and growth.

seekingalpha.com2026-07-10

Innovative Industrial Properties: Capital Structure Risk Solved, 9% Preferred Yield Remains

Innovative Industrial Properties (IIPR) navigated a $290M bond maturity by issuing preferred equity and later securing cheap senior unsecured debt. IIPR.PR.A preferred shares experienced a sharp drawdown due to capital structure decisions, not deteriorating fundamentals, and have since rebounded. IIPR's balance sheet remains robust with a Debt/Assets ratio of 0.14 and a debt service coverage ratio of 10.4x.

seekingalpha.com2026-07-06

Innovative Industrial Properties Preferred: High Income Yield But Not A Buy-And-Hold Allocation

Innovative Industrial Properties Series A preferred shares offer an ~9.17% yield but are best suited for short-term, moderate allocations. IIPR.PR.A trades just below par, post-call date, exposing investors to negative convexity and heightened interest-rate sensitivity, limiting upside if rates decline. IIPR's low leverage and robust common equity base (~$1.8B) provide strong coverage for preferred obligations, with 19x earnings coverage on preferred dividends.

seekingalpha.com2026-06-30

Innovative Industrial Properties: Cannabis Rescheduling Progress Reinforces The Re-Rating Thesis

Innovative Industrial Properties remains a Strong Buy, with a compelling valuation, robust balance sheet, and a double-digit dividend yield. IIPR's AFFO was stable at $1.88/share, leverage is still low for a REIT, and recent capital raises support both investments and buybacks. Upcoming cannabis rescheduling could materially improve tenant health, expand the client base, and drive long-term growth and re-rating potential.

zacks.com2026-06-26

Innovative Industrial Properties (IIPR) Increases Despite Market Slip: Here's What You Need to Know

Innovative Industrial Properties (IIPR) reached $62.93 at the closing of the latest trading day, reflecting a +2.89% change compared to its last close.

zacks.com2026-06-18

Innovative Industrial Properties (IIPR) Exceeds Market Returns: Some Facts to Consider

Innovative Industrial Properties (IIPR) concluded the recent trading session at $59.6, signifying a +1.62% move from its prior day's close.

247wallst.com2026-06-18

KBWY Up 20% This Year, But The Real Test Comes When Rent Rolls Reset

Income hunters know Invesco KBW Premium Yield Equity REIT ETF (NASDAQ:KBWY) as one of the highest-yielding equity REIT funds on the market, with a 30-day SEC yield of 8.26% and a 12-month distribution rate of 8.6%.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"IIPR reported Q1 2026 Revenue of $68.999M and Net Income of $30.155M (EPS $1.08; diluted $1.02). YoY, Revenue declined from $71.722M in Q1’25 to $68.996M in Q1’26 (about -3.8%), while Net Income rose from $31.077M to $30.155M (about -3.0%). QoQ, Revenue increased from $66.657M in Q4’25 to $68.996M in Q1’26 (+3.5%), and Net Income fell from $31.841M to $30.155M (-5.3%). Profitability remains very strong for this period, with Q1’26 gross margin at ~89.0% and net margin at ~43.7%. Across the last four quarters, gross margin stayed high but has been somewhat volatile (notably lower in Q4’25). Net margin contracted vs Q4’25 (47.8% to 43.7%), suggesting costs/other line items were less favorable sequentially. Cash generation was solid: operating cash flow was $56.031M and free cash flow was $56.031M. The company paid $1.002M in dividends and had no common buybacks reported in Q1’26. Balance sheet resilience is supported by sizable cash ($89.1M) and stable equity ($1.895B), though leverage remains meaningful with long-term debt of $366.0M. Total shareholder returns are modest based on available performance data: the stock is up ~3.9% over the last year and shows no buyback support in Q1’26. With limited dividend yield (~0.07%), appreciation appears to be the primary driver, but momentum is not strong (<20% 1y)."

Revenue Growth

Neutral

QoQ Revenue increased +3.5% ($66.657M to $68.996M) but YoY Revenue decreased about -3.8% ($71.722M to $68.996M), indicating mild contraction with some sequential improvement.

Profitability

Positive

Gross margin remains very high (~89.0%) but net margin contracted QoQ (47.8% in Q4’25 to 43.7% in Q1’26). YoY net income is slightly lower (~-3.0%), implying profitability softened sequentially.

Cash Flow Quality

Positive

Operating cash flow was strong at $56.0M with free cash flow equal to $56.0M in Q1’26. Dividends paid were relatively small ($1.0M) versus net income, supporting coverage and optionality.

Leverage & Balance Sheet

Fair

Equity was stable and sizable ($1.895B) while total assets were steady (about $2.394B). Debt remains material (long-term debt $366.0M; net debt ~$276.9M), so balance sheet strength is moderate rather than defensive.

Shareholder Returns

Fair

No evidence of buybacks in Q1’26 and dividends appear small (dividend yield ~0.07%). Stock performance is positive but not momentum-driven (+3.9% 1y_change), limiting total return support.

Analyst Sentiment & Valuation

Positive

Valuation multiples shown are reasonable for the current profitability (e.g., P/E ~11.6, price-to-book ~0.74). Analyst target consensus ($84.67) implies upside to the current price (~$52.94), supporting sentiment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

IIPR’s Q1 2026 results were supported by portfolio monetization events tied to tenant restructurings and stabilized leasing. Revenues rose to $69.0m (+3.5% vs Q4) mainly from PharmaCann payments ($3.2m), while AFFO was $53.4m ($1.88/share), in line with the prior quarter. Management’s key narrative is the transition to federal Schedule III for qualifying medical operators, which they view as the biggest industry catalyst since 2016, potentially eliminating 280E for medical operators and improving operator economics and capital access. Operationally, leasing progress is tangible but execution timing remains dependent on licensing and approvals: Gold Flora is fully re-leased; 4Front is largely stabilized via tentative agreements (~488k sf) tied to receivership conclusion; PharmaCann is resolved and re-leased with new tenants (Grown Rogue, Curaleaf). Financially, the company is actively de-risking its unsecured bond maturity with $128m raised year-to-date and multiple ~8% blended-rate financings (~$130m total) pending closure, while liquidity remains strong (~$177m).

AI IconGrowth Catalysts

  • DOJ/ag acting Attorney General final order moving FDA-approved medical cannabis products (and state-licensed medical operators’ cannabis) to Schedule III, eliminating 280E burden for qualifying medical operators and setting expedited DEA hearing timeline
  • Texas Compassionate Use Program awarding conditional licenses to tenant partners Green Thumb Industries and Cresco Labs, expanding in-state medical program footprint
  • Portfolio leasing momentum: 4 new leases totaling ~331,000 sq ft signed in Q1, plus earlier execution/stabilization across Gold Flora, PharmaCann, and 4Front assets

Business Development

  • IQHQ life science JV/commitment: $175 million funded to date of a $270 million commitment
  • Texas Compassionate Use Program: conditional licenses awarded to Green Thumb Industries and Cresco Labs (plus mentions of Texas Original, Trulieve, Verano already in market)
  • Leasing / retenanting and tenant names: Grown Rogue (Dwight, IL), Curaleaf (Ohio, 58,000 sq ft), Battle Green (Columbus, OH; defaulted March), Holistic (Ohio; mentioned by analyst as taking over operations), plus multiple other tenant partners referenced (e.g., PharmaCann resolution, 4Front tentative tenants subject to diligence/licensing)

AI IconFinancial Highlights

  • Total revenues: $69.0 million, +3.5% vs Q4 2025; increase primarily from PharmaCann payments of $3.2 million
  • AFFO: $53.4 million, or $1.88/share, in line with Q4 2025
  • Administrative rents: $1.5 million received in Q1 as settlement of remaining unpaid administrative rents due from Gold Flora receivership
  • Leasing inflows/earnings support: management highlighted triple-net expense transfers upon lease execution as an additional earnings pickup
  • No explicit bps margin change disclosed in transcript; credit metrics emphasized instead (debt service coverage >11x; net debt/adjusted EBITDA 1.1x)

AI IconCapital Funding

  • Raised $128 million of gross proceeds year-to-date (preferred equity $72m, common equity $36m, secured debt $20m via 3-year secured term loan at fixed 9%)
  • Pursuing additional secured/unsecured financings totaling nearly $130 million; $56.5 million financing expected to be funded today with stated rate 8.75%
  • Blended rate of just over 8% expected based on terms under discussion (subject to contingencies/closing)
  • Liquidity as of March 31: ~$177 million total (cash $89m; revolver availability $87.5m)
  • Primary capital objective: address unsecured bond maturity this month; management positioned balance sheet for growth in 2026

AI IconStrategy & Ops

  • Leasing execution in Q1: signed new leases at 4 properties totaling ~331,000 sq ft
  • Gold Flora former assets fully leased: all 3 properties totaling ~330,000 sq ft leased (Palm Springs 70,000 sq ft; Desert Hot Springs 204,000 sq ft; Palm Springs 56,000 sq ft)
  • 4Front stabilization: reached tentative agreements for all 4 properties totaling ~488,000 sq ft (Illinois, Washington, Massachusetts), subject to diligence, licensing approvals, and expected commencement after receivership conclusion later in 2026
  • PharmaCann: resolved all pending litigation related to lease defaults; executed new leases in March/April (Grown Rogue in Dwight, IL; Curaleaf in Ohio) and described active retenanting of returning properties later this month
  • Pennsylvania portfolio: regained possession of a 270,000 sq ft property on April 15 and is in active discussions with a new tenant
  • Columbus, Ohio Battle Green: defaulted in March; company enforcing rights including commencing eviction proceedings and pursuing remedies under applicable guarantees
  • Life science environment: cited stabilization/improving momentum in 2026 with demand near pre-pandemic levels; new development down; pipeline historically low

AI IconMarket Outlook

  • IQHQ investment timing: scheduled investments through mid-2027; management noted ability to bring forward a couple scheduled investments as accretive transactions
  • Rescheduling hearing timeline: expedited process expected to be wrapped within 30 days after hearings begin June 29; management expects clear resolution including medical vs adult-use treatment by conclusion of hearing
  • Near-term priority: complete refinancing of unsecured debt and complete IQHQ commitment before pursuing additional acquisitions for 2H 2026/into 2027

AI IconRisks & Headwinds

  • Persistent inflation, elevated interest rates, and broader macroeconomic headwinds cited as ongoing operating challenges
  • All additional financings are subject to contingencies and not assured to close on contemplated terms
  • Lease commencement risk: free rent periods and licensing/approval timing can delay revenue impact; multiple leases are tentative/nonbinding and subject to receivership/diligence/licensing approvals
  • Tenant credit/workout risk persists even with 280E relief: management stated businesses can still grow/shrink/disappear; 280E improves operating environments but does not eliminate business risk

Q&A: Analyst Interest

  • Leasing timing/modeling: Management explained that executed leases typically require regulatory approval, license transfer, and can include free-rent periods averaging ~3 to 12 months and up to 18 months; they also emphasized that triple-net expense transfers generally occur at lease execution, supporting earnings when rent starts.
  • Schedule III mechanics & 280E: Management clarified that licensed medical operators are covered by Schedule III immediately (100% of its tenants hold medical licenses), while the broadened hearing begins June 29 with an expedited 30-day timeline for adult-use treatment; they expect retroactive 280E relief for qualifying medical operators and noted Treasury guidance may follow sooner.
  • IQHQ incremental investments: Management stated IQHQ preferred/commitment investments are scheduled through mid-2027, with some investments brought forward opportunistically due to accretiveness—average yield north of 14% versus ~6% cost of capital on their credit facility—while reiterating priority on unsecured debt refinancing first before new acquisitions.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the IIPR Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for IIPR.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (IIPR)

© 2026 Stock Market Info — Innovative Industrial Properties, Inc. (IIPR) Financial Profile